EVOK   $4.2  -4.76% Market Closed

Evoke Pharma Inc
Total Cash 9.18M
totalCashPerShare 12.49
EBITDA
Total Debt 5.00M
quickRatio 1.181
currentRatio 1.281
Total Revenue 7.53M
debtToEquity 187.62
Revenue/Share 10.241
ROA -0.36798
ROE -4.0759697
grossProfits
freeCashflow -1.85M
operatingCashflow -5.55M
earningsGrowth
revenueGrowth 1.255
grossMargins 0.96971
ebitdaMargins 0.0
operatingMargins -0.47957
profitMargins -0.86747
enterpriseValue 76.86K
forwardPE 24.125
floatShares 536.36K
sharesOutstanding 819.27K
sharesShort 25.99K
sharesShortPriorMonth 65.62K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.33%
Short Ratio help_outline 0.65%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 3.627
Price To Book help_outline 1.60
earningsQuarterlyGrowth
netIncomeToCommon -6.53M
trailingEps -15.89%
forwardEps 0.24%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.38 3Q 2024
institutionsCount 16
lastUpdated Nov. 6, 2024, 5:23 p.m.